» Articles » PMID: 34199095

Myoinositol Reduces Inflammation and Oxidative Stress in Human Endothelial Cells Exposed In Vivo to Chronic Hyperglycemia

Overview
Journal Nutrients
Date 2021 Jul 2
PMID 34199095
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Myo-inositol (Myo) improves insulin resistance, glucose metabolism, and helps gestational diabetes (GDM) management. GDM is associated with a pro-inflammatory state and increased oxidative stress, which are both involved in vascular damage in diabetes. Our aim was to study Myo anti-inflammatory/antioxidant potential effects on an in vitro model of human umbilical vein endothelial cells (HUVECs). To this end, monocyte cell adhesion to HUVECs, adhesion molecule membrane exposure, and oxidative stress levels were determined in cells from control (C-) and GDM women treated during pregnancy either with diet only (GD-) or with diet plus Myo (GD+Myo). To deeply study the vascular effects of Myo, the same evaluations were performed in C- and GD-HUVECs following 48 h in vitro stimulation with Myo. Notably, we first observed that GD-HUVECs obtained from women assuming Myo supplementation exhibited a significantly decreased number of monocytes that adhered to endothelial cells, less adhesion molecule exposure, and lower intracellular reactive oxygen species (ROS) levels in the basal state as compared to GD-HUVECs obtained from women treated by diet only. This Myo anti-inflammatory/antioxidant effect was confirmed by 48 h in vitro stimulation of GD-HUVECs as compared to controls. Altogether, these results strongly suggest that Myo may exert protective actions against chronic inflammation induced by endothelial dysfunction in diabetes.

Citing Articles

The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases.

Quecchia C, Vianello A Int J Mol Sci. 2025; 26(5).

PMID: 40076806 PMC: 11901072. DOI: 10.3390/ijms26052185.


Research Progress on Anti-Inflammatory Mechanism of .

Wu N, Wang S, Zhang Y, Wang S Int J Mol Sci. 2025; 26(5).

PMID: 40076538 PMC: 11900443. DOI: 10.3390/ijms26051911.


Chemical Composition of Mexicali Propolis and Its Effect on Gastric Repair in an Indomethacin-Induced Gastric Injury Murine Model.

Dominguez-Verano P, Jacobo-Herrera N, Castell-Rodriguez A, Canales-Alvarez O, Canales-Martinez M, Rodriguez-Monroy M Antioxidants (Basel). 2025; 14(1).

PMID: 39857399 PMC: 11762497. DOI: 10.3390/antiox14010065.


The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome.

Ricottini L, Basciani S, Spizzichini M, de Mattia D, Coniglio-Iannuzzi Delle Noci M, Sorrentino S Nutrients. 2024; 16(23.

PMID: 39683371 PMC: 11643896. DOI: 10.3390/nu16233977.


The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis.

Ghaemi M, Seighali N, Shafiee A, Beiky M, Kohandel Gargari O, Azarboo A Food Sci Nutr. 2024; 12(11):8515-8524.

PMID: 39619962 PMC: 11606893. DOI: 10.1002/fsn3.4427.


References
1.
Estampador A, Franks P . Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders. Diabetes Metab Syndr Obes. 2014; 7:575-86. PMC: 4257022. DOI: 10.2147/DMSO.S51433. View

2.
Benvenga S, Feldt-Rasmussen U, Bonofiglio D, Asamoah E . Nutraceutical Supplements in the Thyroid Setting: Health Benefits beyond Basic Nutrition. Nutrients. 2019; 11(9). PMC: 6770945. DOI: 10.3390/nu11092214. View

3.
Lagana A, Unfer V, Garzon S, Bizzarri M . Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?. Med Hypotheses. 2020; 144:110262. PMC: 7480225. DOI: 10.1016/j.mehy.2020.110262. View

4.
Ceriello A . New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care. 2003; 26(5):1589-96. DOI: 10.2337/diacare.26.5.1589. View

5.
Matarrelli B, Vitacolonna E, DAngelo M, Pavone G, Mattei P, Liberati M . Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013; 26(10):967-72. DOI: 10.3109/14767058.2013.766691. View